1. Sun Z, Sun X, Yuan Y, Li H, Li X, Yao Z. FCGR2B as a prognostic and immune
microenvironmental marker for gliomas based on transcriptomic analysis. Medicine
(Baltimore). 2023 Sep 15;102(37):e35084. doi: 10.1097/MD.0000000000035084. PMID:
37713871; PMCID: PMC10508392.
2.Alee I, Chantawichitwong P, Leelahavanichkul A, Paludan SR, Pisitkun T,
Pisitkun P. The STING inhibitor (ISD-017) reduces glomerulonephritis in
129.B6.Fcgr2b-deficient mice. Sci Rep. 2024 May 14;14(1):11020. doi:
10.1038/s41598-024-61597-z. PMID: 38745067; PMCID: PMC11094069.
3.Xu Z, Moreno-Giró À, Zhao D, Krämer A, Pandey RK, Xu B, Lundström SL,
Holmdahl R. Fcgr2b and Fcgr3 are the major genetic factors for cartilage
antibody-induced arthritis, overriding the effect of Hc encoding complement C5.
Eur J Immunol. 2024 Apr;54(4):e2350659. doi: 10.1002/eji.202350659. Epub 2024
Feb 5. PMID: 38314895.